Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBS-007 in Relapsed or Resistant Acute Leukaemias
NCT05756322Phase 2Recruiting
- Sponsor
- Lin BioScience, Inc.
- Start
- Jul 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of granaticin b in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Lin BioScience, Inc.. Started Jul 2023; status: recruiting.
02
Drugs
granaticin b
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT05756322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05756322.